TRUST POINT INC.: AMBA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of TRUST POINT INC. on AMBA, newest first. How the timeline and the estimate are built.
TRUST POINT INC. held 0 AMBA shares at 2025-12-31 per its 13F-HR filed 2026-01-13.
the latest 13F is the newest step
- period ended2025-12-3113F 0 sharesChange vs previous 13F -3,884 shares
13F-HR 0001635633-26-000001 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-09-3013F 3,884 sharesChange vs previous 13F +238 shares
0.03% of the 13F portfolio, value $320,506.
13F-HR 0001635633-25-000009 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 3,646 sharesChange vs previous 13F -2,902 shares
0.02% of the 13F portfolio, value $240,876.
13F-HR 0001635633-25-000004 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 6,548 sharesChange vs previous 13F -4,012 shares
0.03% of the 13F portfolio, value $329,561.
13F-HR 0001635633-25-000003 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 10,560 sharesChange vs previous 13F +497 shares
0.05% of the 13F portfolio, value $768,132.
13F-HR 0001635633-25-000001 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 10,063 sharesChange vs previous 13F not available
0.04% of the 13F portfolio, value $567,605.
13F-HR 0001635633-24-000009 filed by TRUST POINT INC.
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).